Status:

COMPLETED

Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System

Lead Sponsor:

National Institute of Neurological Disorders and Stroke (NINDS)

Conditions:

Motor Function of Healthy Physiology

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

Objectives Noninvasive stimulation of the central and peripheral nervous system, including transcranial magnetic stimulation (TMS), transcranial direct and alternating current stimulation (tDCS and t...

Detailed Description

Objectives Noninvasive stimulation of the central and peripheral nervous system, including transcranial magnetic stimulation (TMS), transcranial direct and alternating current stimulation (tDCS and t...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Age 18 and older
  • Willingness and ability to give consent
  • Normal neurological examination
  • Clearly dominant handedness (right or left) as assessed by Handedness scales
  • EXCLUSION CRITERIA:
  • Any severe or progressive neurological disorder or severe medical condition, or history of seizures
  • Chronic use of medications acting primarily on the central nervous system, which lower the seizure threshold or significantly alter cortical excitability such as antipsychotic drugs (chlorpromazine, clozapine), tricyclic or other antidepressants, or prescription stimulants.
  • Pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and cochlear implants), permanent eyeliner, implanted delivery pump, or shrapnel fragments
  • Diagnosis of drug dependence made by a health care provider (ICD-9-CM code 304)
  • Staff from our section

Exclusion

    Key Trial Info

    Start Date :

    January 14 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 20 2019

    Estimated Enrollment :

    1007 Patients enrolled

    Trial Details

    Trial ID

    NCT00453505

    Start Date

    January 14 2007

    End Date

    December 20 2019

    Last Update

    January 8 2026

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892